Breast cancer drug tamoxifen recommended for 'high risk' women (BBC News Online, 15 January 2013)

15 Jan 2013


The National Institute for Health and Clinical Excellence (NICE) has launched a consultation on using the breast cancer drug tamoxifen as a preventative medicine in women with a family history of breast cancer.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story